News Column

DURATA THERAPEUTICS, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers

August 28, 2014



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 25, 2014, Ronald M. Hunt resigned as a member of the Board of Directors (the "Board") of Durata Therapeutics, Inc. (the "Company"). His resignation did not arise from any disagreement on any matter relating to the Company's operations, policies or practices.

On August 25, 2014, the Board elected two new directors, J. Martin Carroll and Wendy L. Yarno.

Mr. Carroll was elected to fill the vacancy on the Board created by the resignation of Mr. Hunt and was designated as a Class III member of the Board, with a term that expires at the Company's annual meeting of stockholders to be held in 2015. Mr. Carroll was also appointed as a member of the Audit Committee and as a member of the Nominating and Corporate Governance Committee.

Ms. Yarno was elected to fill a previous vacancy on the Board created by the resignation of James I. Healy in November 2013 and was designated as a Class II member of the Board, with a term that expires at the Company's annual meeting of stockholders to be held in 2017. Ms. Yarno was also appointed as the new Chair of the Nominating and Corporate Governance Committee and as a member of the Organization and Compensation Committee.

Mr. Carroll and Ms. Yarno will be eligible for benefits under the Company's existing non-employee director compensation policy.

--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters